The Termeer Foundation’s Post

Two years of challenging public markets have strained the strategies of biotechs and their investors. This Citeline panel session, moderated by Daniel Chancellor, Director, of Thought Leadership and Consulting at Citeline, unveils insights from a recent Citeline study into Series A funding rounds and reveals the science that continues to attract investment while discussing the challenges ahead for biotechs at this earliest stage of development. Join the panel at BIO Europe Spring on March 18th at 10:30 am in room 112, which features Dan, as well as leaders across the continuum of founders, CEOs, and venture capitalists. https://ow.ly/ZzZ450QUn51 #BioEuropeSpring #BIOEU24 #Barcelona

So excited to learn from these experts! Their diverse backgrounds and expertise will provide a comprehensive view of IP strategy and management for medical & bio-innovations 🚀 

🔍 What does it take to successfully scale in #HealthTech to Series B & beyond? In the HealthTech Breakfast Club February's edition the conversation delved deeper into the process of scaling beyond Series B funding, including the cohesion of leadership teams and strategic considerations regarding organic vs. inorganic growth. From looking at growth metrics to M&A target assessment when thinking about multiples, valuation and future integration both of tech and people. This month's panel was made up of: 🔹Dr. Ben Maruthappu - CEO of Cera 🔹Mong-Trang Sarrazin - CFO of Unmind 🔹Ian Coyne - Partner at Coulter Partners 🔹Michael Treskow - Partner at Eight Roads Key takeaways from the session: 🏷 Flexibility in leadership is crucial, both in response to overarching trends and when confronted with growth hurdles during the business's expansion. 📜 Domain expertise proves vital even in the early stages, enabling informed decision-making for both organic and strategic growth initiatives. This expertise also fosters credibility with investors, whether equity or debt stakeholders. 📦 Understanding unit economics is imperative for scaling operations. A meticulous focus on metrics like Customer Acquisition Cost (CAC) to Customer Lifetime Value (CLTV) for organic growth, as well as having a deep comprehension of the financial dynamics behind potential acquisitions. 🔒 M&A serve as vehicles for market expansion or product diversification. Recognizing the underlying purpose is pivotal to anticipate and address integration challenges, whether they pertain to technology infrastructure, personnel dynamics, or cultural alignment. Identifying and mitigating risks associated with execution is paramount. 🗝 Founders venturing into the healthtech sector face a distinctive risk profile. While they may exhibit a greater willingness to challenge conventional norms compared to counterparts in other industries, prioritize assembling a capable leadership team early on is key to realize their ambitious vision. Special thanks to Eight Roads for hosting this month's session at their offices and supporting this event. With Molly Gilmartin, Investment Manager AlbionVC An exciting new #TechBio chapter is coming up in March with Leigh Brody, click here to learn more: https://lnkd.in/eiPk7mGf #community #vc #founders #operators #experts #investors #venturecapital #healthcare #techbio #growth #seriesB #digitalhealth #leadershipteam #scaling

“As a sector-specific executive search firm, we are actively supporting biotech companies building human capital to ensure success. Given the unique nature of the life sciences and biotech community, we use our global capabilities to find the right roles, matching the needs of these business builders. This is particularly pertinent for biotech companies addressing challenging therapeutic requirements,” says Christopher Coe, senior partner, global life sciences practice, at Kingsley Gate. He recommends that biotech organizations consider specific key roles (Chair/CSO/R&D) to articulate their scientific value proposition for a future-ready business and attract the capital required for strong growth.   To read the full Forbes articles on “The Determined Entrepreneur With Her ‘Eyes On The Future’”, visit https://lnkd.in/dzNScmwk     #KingsleyGate #LifeSciences #biotech #leadership

The #STATinNYC event last night offered a fascinating preview into the biotech landscape of 2024. A couple of key takeaways stood out to me, particularly from my professional development perspective. These include insights from: Dr. Andrea Califano, President at Chan Zuckerberg Biohub New York, gave an exciting behind-the-scenes look at the development of #czbiohubny. The focus was on assembling a multidisciplinary 'dream team' that will bring together deep knowledge and diverse expertise. Very exciting times for STEM talent in NYC. This is a brilliant example of harnessing diverse expertise to foster innovation. Dr. Behzad Aghazadeh, Managing Partner at Avoro Capital, emphasized the critical need for trained leaders in the management teams of both emerging and established biotech firms. Attracting investors requires demonstrating that your team possesses the skills to collaborate, succeed, and fail together effectively. This factor is critical in the biotech industry and to your potential investors. A personal conclusion: Yet another reminder that the cornerstone of success is the people. Investing in professional development and training for STEM is not just beneficial; it's essential for achieving success and impact. If that inspires you to look into professional development training for you or your team, I'd love to help.

🌟 We are thrilled to announce the launch of the inaugural Ontario Life Sciences Innovator Award! 🌟 This prestigious award aims to recognize and celebrate the outstanding contributions of an Innovator leading Ontario-based Life Sciences companies that have made a significant impact in the sector. We encourage you to review the criteria and nominate an Innovator who has excelled in one or more of the following areas: 1. Innovation: Introducing groundbreaking technologies, therapies, or products that address unmet medical needs or enhance existing solutions. 2. Economic Growth: Driving job creation and retention and attracting significant investment to fuel Ontario's life sciences ecosystem. 3. Disruptive Impact: Leading advancements in scientific research, resulting in new discoveries, publications, and patents that position Ontario at the forefront of the global life sciences sector. 4. Health Outcomes: Enhancing patient care, treatment efficacy, and overall public health through the implementation of cutting-edge medical technologies or practices. Nominate an Innovator today and help us shine a spotlight on the leaders shaping the future of life sciences in Ontario! 🌍✨ #LifeSciences #Innovation #OntarioLifeSciences #Healthcare #EconomicGrowth #HealthOutcomes #Awards

🌍 Addressing #GlobalHealth challenges goes beyond innovation alone; it requires a fusion of cutting-edge technologies and partnerships to accelerate. That’s why I am thrilled to share that Novo Nordisk Research & Early Development, MassChallenge, and ICDK Boston are joining forces💡 Since catalyzing the collaboration between ICDK Boston and MassChallenge last year via SDG Landing Pad, it's amazing to see the pilot expand with new partners uniting to amplify novel innovations to transform the future of HealthTech. 🚀

Tezlom: More Than Just a Name Introduction: https://lnkd.in/dczzTpwS Explore the story behind Tezlom, a leader in healthcare staffing, shaped by personal trials and triumphs. Resilience and Legacy: Tezlom, spearheaded by entrepreneur Ryan Armitage, is not just a staffing agency; it's a tribute to family resilience. After a profound personal loss, Ryan transformed his pain into a powerful legacy, driving Tezlom to promote a culture of care and compassion in healthcare. Transformation and Vision: Under Ryan's leadership, Tezlom evolved from its original branding to embody values of transparency and motivation. It's a story of adapting and envisioning beyond traditional boundaries – a narrative that could inspire any sector. Conclusion: What's in a name? For Tezlom, it's a profound story of passion, purpose, and care. How does your business name reflect your values? #Tezlom #HealthcareInnovation #Entrepreneurship More about our channel and subscribe: https://lnkd.in/eDSnrHhN

We’re less than 30 days from thousands of meetings, panels, and spontaneous introductions that will lead to stronger partnerships and deeper insights, so we can grow healthy businesses faster. In this weeks update, I mention one of my favorite backstories about a partnership that was formed at LSI USA '20. Jon Root (USVP) has fondly shared over the years how he met the Shoulder Innovations (SI) team in Dana Point 5 years ago and then ended up investing in their deal. Today, SI is off to the races, performing brilliantly, and no doubt a bright spot in USVP's portfolio. I can't wait to hear more stories like this from the cultivate(MD) team including Rob Ball, David Blue, Matthew Ahearn, and R. Sean Churchill, MD, MBA during their panel (referenced below). Other updates about LSI USA ‘24 and a handful of exciting, new panels we just added to the agenda. 1. Last call to join 1,200+ of the best leaders in Medtech & Healthtech Engage with over 50 panels, keynotes, fireside chats, view 325+ presenting companies, connect with 300+ investors and strategics, and much more. 2. New sessions coming to LSI USA ‘24 We’re continuing to add new sessions that will uncover deep, earned insights that come from decades of experience in the industry: → cultivate(MD): From the Kernel of an Idea to Harvesting an Exit → Investing for the Long-Haul: Supporting Companies and Aligning Investors Across Stages → Does Venture Scale? Fund Size Logic, Considerations, and Misconceptions I hope you will join us in Dana Point to connect with senior decision-makers and leadership from the world’s most influential Medtech strategics and investors. Secure your spot here while our last call is still open: https://lnkd.in/ewkMgzy3 See you in Dana Point.

#Thankyou for recognition and kind words Eva McLellan from Roche. The critical skill gaps identified in report created by WorkInHealth Foundation / EIT Health together with European Investment Fund (EIF) are a call to action for all of us. Leadership and management skills are indeed paramount, and I thank you for being committed to driving this transformation forward in such a great initiatives like #BILDAI Institut. Sharing your invaluable knowledge and experiences in interview for Future Health HERos, initiative created by WorkInHealth Foundation will for sure inspire many women to proceed into Healthcare career. Your insights into leadership are truly inspiring , and there's so much we can learn from the remarkable work you're already doing in this field. Let's continue to lead, innovate, and take the necessary steps to close these gaps. The time for action is now! Link 🔗 to report: https://lnkd.in/dX3KZxKE Lenja Faraguna #leadership #healthinnovation #talentgap #skillsgap #skillsreport